E2 ModerateWeak / uncertainPEM not requiredObservationalPeer-reviewedReviewed
Standard · 3 min
Peripheral blood gene expression in postinfective fatigue syndrome following from three different triggering infections.
Galbraith, Sally, Cameron, Barbara, Li, Hui et al. · The Journal of infectious diseases · 2011 · DOI
Quick Summary
Researchers studied blood samples from 18 people who developed long-lasting fatigue after three different infections (Epstein-Barr virus, Ross River virus, and Q fever) and compared them to 18 healthy people who recovered normally. They looked for patterns in which genes were turned on or off that might explain the fatigue syndrome. While they found some differences in gene activity, these patterns were not consistent across the different infection groups, suggesting there may not be a single blood-based marker that identifies post-infectious fatigue.
Why It Matters
This study is important because it directly addresses whether blood-based gene expression signatures can identify or explain ME/CFS, a key question for developing diagnostic tests and understanding disease mechanisms. The inclusion of multiple infection triggers and longitudinal sampling provides valuable evidence about whether postinfective fatigue syndromes share a common biological signature, which has implications for treatment strategies.
Observed Findings
23 genes showed modest differential expression (0.6–2.3-fold change) when comparing early symptomatic to late recovered time points within individual subjects.
63 genes showed modest differences in cross-sectional comparisons at 6 months post-infection or in regression models.
223 genes were significantly correlated with specific symptom domains.
33 of 45 genes selected for quantitative PCR confirmation (73%) replicated.
No gene expression patterns were consistent across all three infection cohorts (EBV, Ross River virus, Q fever).
Inferred Conclusions
Although patients with postinfective fatigue syndromes triggered by different infections share similar clinical characteristics, they do not share a common peripheral blood gene expression signature.
Peripheral blood transcriptomics alone may not be sufficient to identify a reliable biological correlate or diagnostic marker for postinfective fatigue syndrome.
Gene expression changes associated with fatigue symptoms are inconsistent across infection types, suggesting either distinct biological mechanisms or the need to examine tissues and cell types beyond peripheral blood.
Remaining Questions
Why do postinfective fatigue syndromes triggered by different infections have similar clinical presentations if they lack a common gene expression signature?
What This Study Does Not Prove
This study does not prove that ME/CFS has no biological basis—it only shows that a single, consistent gene expression signature in peripheral blood may not exist across different triggering infections. The absence of a universal biomarker does not rule out abnormalities in other tissues, immune cell subtypes, or alternative biological mechanisms. Lack of consistent findings across cohorts may reflect genuine biological differences between infection-triggered syndromes rather than absence of pathology.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
Would examining specific immune cell populations or other tissues (e.g., muscle, brain) reveal consistent biological abnormalities across infection types?
Are the modest gene expression differences observed meaningful at the individual patient level for diagnosis or prognosis?
What biological mechanisms underlie the symptom-correlated gene expression changes that were not consistent across cohorts?